Embecta (NASDAQ:EMBC) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.71, beating the consensus estimate of $0.67 by $0.04 per share. Revenue came in at $261.2M, beating the estimate of $258.1M.
Embecta's stock moved following the earnings release. The stock currently trades at $10.87 with a market capitalization of $699.2M.